Tru Independence Asset Management 2, LLC Merck & Co., Inc. Transaction History

Tru Independence Asset Management 2, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 20, 2022	SELL	$72.28 - $90.54 $213,442 - $267,364	-2,953 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$71.68 - $78.83 $211,671 - $232,784	2,953 New	2,953 $222,000
Q1 2021 May 19, 2021	SELL	$68.86 - $81.11 $70,374 - $82,894	-1,022 Closed	0 $0
Q4 2020 Mar 09, 2021	BUY	$71.77 - $79.65 $73,348 - $81,402	1,022 New	1,022 $84,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Tru Independence Asset Management 2, LLC, based on Form 13F filings with the SEC.

Stay updated on Tru Independence Asset Management 2, LLC with notifications on news.